We acknowledge the support of Tseganesh Selameab, MD; Larisa Turin, RN; Fatima Hassan, MD; the staff of HealthPartners Center for International Health; and Richard Wallace, Senior Application Analyst & Developer, HealthPartners.
Global Hepatitis Programme, Department of HIV/AIDS , 2016. Combating Hepatitis B and C to Reach Elimination by 2030. Geneva, Switzerland: World Health Organization.
Fattovich G, Bortolotti F, Donato F, 2008. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 48: 335–352.
Pungpapong S, Kim WR, Poterucha JJ, 2007. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 82: 967–975.
McMahon BJ et al., 2012. Internist diagnosis and management of chronic hepatitis B virus infection. Am J Med 125: 1063–1067.
Juday T, Tang H, Harris M, Powers AZ, Kim E, Hanna GJ, 2011. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment. J Gen Intern Med 26: 239–244.
- Search Google Scholar
- Export Citation
Juday T Tang H Harris M Powers AZ Kim E Hanna GJ 2011. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment. J Gen Intern Med 26: 239– 244. 10.1007/s11606-010-1549-9
Wu Y et al., 2014. Poor adherence to AASLD guidelines for chronic hepatitis B Management and treatment in a large academic medical center. Am J Gastroenterol 109: 867–875.
Wong CR et al., 2009. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci 54: 2712–2721.
Abara WE et al., 2017. Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med 167: 794–804.
Chak EW, Sarkar S, Bowlus C, 2016. Improving healthcare systems to reduce healthcare disparities in viral hepatitis. Dig Dis Sci 61: 2776–2783.
Zhou K, Terrault NA, 2020. Gaps in viral hepatitis awareness in the United States in a population-based study. Clin Gastroenterol Hepatol 18: 188–195 e184.
Centers for Disease Control and Prevention , 2020. Viral Hepatitis Surveillance—United States, 2018. Available at: https://www.cdc.gov/hepatitis/statistics/SurveillanceRpts.htm. Accessed February 23, 2020.
Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL, 2012. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology 56: 422–433.
Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA, 2011. The increasing burden of imported chronic hepatitis B—United States, 1974–2008. PLoS One 6: e27717.
Mendu ML et al., 2019. Development of an electronic health record-based chronic kidney disease registry to promote population health management. BMC Nephrol 20: 72.
Jaffe MG, Lee GA, Young JD, Sidney S, Go AS, 2013. Improved blood pressure control associated with a large-scale hypertension program. JAMA 310: 699–705.
Grant RW et al., 2004. A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care 27: 2299–2305.
Hoque DME, Kumari V, Hoque M, Ruseckaite R, Romero L, Evans SM, 2017. Impact of clinical registries on quality of patient care and clinical outcomes: a systematic review. PLoS One 12: e0183667.
Terrault NA et al., 2018. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67: 1560–1599.
Hyun CS, Ko O, Lee S, McMenamin J, 2019. Long term outcome of a community-based hepatitis B awareness campaign: eight-year follow-up on linkage to care (LTC) in HBV infected individuals. BMC Infect Dis 19: 638.
Kikuchi M et al., 2022. Development of an intervention system for linkage-to-care and follow-up for hepatitis B and C virus carriers. Hepatol Int 16: 68–80.
Frenette CT, Isaacson AJ, Bargellini I, Saab S, Singal AG, 2019. A practical guideline for hepatocellular carcinoma screening in patients at risk. Mayo Clin Proc Innov Qual Outcomes 3: 302–310.
Wang Q et al., 2012. Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma. J Dig Dis 19: 638.